Individual diagnosis of your tumor

We have helped many tumor patients

Our satisfied customers

Awarded by our patients on Google

We will find personalized therapy options for you

Jan Zimmermann

5/5

I was diagnosed with an oesophageal tumor in April 2024 and, thanks to the doctors’ quick response, I was able to

start chemotherapy relatively early. In parallel I was undergoing complementary cancer treatment during which I also learned about iQMedix. Based on the information from a Metavectum Complete Test, I obtained and took the recommended natural remedies.
I have now beaten the cancer and what can I say, the chemo played its part, but I am sure that the complementary treatment and the natural remedies of the iQMedix test were decisive for my healing! Thank you very much, keep up the good work!

Maike Winkelmann

5/5

More clarity and confidence thanks to iQMedix – individual guidance, sound advice, human support
The iQMedix test was a

A real turning point for me. I am living with metastatic breast cancer (including in the lungs, liver and bones) and had water in the pleural cavity on both sides – a situation with a rather poor prognosis. The iQMedix blood test helped me to better tailor my combined therapy (conventional medicine and the Jane McLelland protocol) to my individual tumor.
I was able to get to know the “enemy” better – in other words, find out which factors specifically promote tumor growth. This gave me certainty and a clear strategy.
I was particularly impressed by the expertise and commitment I experienced at iQMedix. My therapist was able to integrate the results directly into my treatment. That was a great support on my journey.
The best moment came with the latest CT results – a real ray of hope: The tumors have receded, the water in the pleural space is completely gone on one side and significantly reduced on the other. No new metastases. And the conspicuous lymph node on the right has completely disappeared.
I am very grateful – and can recommend iQMedix with the utmost conviction.

Rainer Neumann

5/5

My doctor explained to me how iQMedix works and took blood for analysis. I find the approach of iQMedix

exciting and, from my point of view (I’m just a patient), innovative.My doctor explained the very detailed results to me. That was 10 months ago, since then I have been following the suggestions and my condition has stabilized positively. In addition to the conventional medical approaches, the iQMedix approach is amazingly logical and has obviously been effective in my case so far.

Ingrid Müller-Raiser

5/5

A Metavectum iComplete test was carried out on my husband’s blood sample, so he could see which

herbal substances – without side effects – and later chemotherapeutics really helped him. He beat his cancer in a very short time. A thousand thanks to the informed doctor.

Our innovative approach to personalized cancer diagnostics supports patients at every stage – from early detection to advanced treatment. Through molecular biological analysis, we identify the individual characteristics of each tumor and its weak points. Discover our specific offers.

Diagnostics
0 +
Our customer satisfaction
0 /5
Affiliated practices
0

As a physician, I am always looking for reliable labs to help me manage my patients’ conditions. I was recently diagnosed with prostate cancer and began looking for ways to complement and enhance conventional treatments. I was impressed with these tests, so I traveled from the US to Germany to meet the company’s executives and perform the iComplete test on myself.

iQMedix has provided valuable genetic information about my specific cancer and has been helpful in the treatment of my tumor.

I can honestly say that this company is run by good people with good intentions. People who are motivated by the possibilities of helping people and not by money. I am grateful for their help and hospitality and will continue to support their efforts now and in the future. I look forward to offering the iQMedix tests in my practice and introducing this technology to my colleagues in the US.

Dr. Anthony Faro

Doctor

Case study Beate S.

04.2020

Diagnosis Microinvasive multifocal breast carcinoma with extensive marginal DCIS

05.2020

Therapy: April 2020 subcutaneous mastectomy on the left. May 2020 secondary axillary LNE on the left

06.2020

1. metavectum test, taking the supplements and infusions

02.2021

2. metavectum test, after complementary therapy

11.2021

3. metavectum test, after complementary therapy

03.2022

4. metavectum test

2022

Complete remission and return of cancer markers to the normal range

2024

Still no signs of disease 2 years after complete remission

Stage 3 breast cancer

Lymph node infestation

52 years, female

Case study Beate S.

Case study Lukas P.

02.2021

12 cm lymphoma in the groin with severe pain, takes morphine tablets

after 4 weeks

Metavectum test: The patient takes nutritional supplements and starts a strict ketogenic diet, the lymphoma shrinks by half (6.5 cm). The patient is pain-free.

after 6 months

The patient undergoes standard chemotherapy and is in complete remission after 6 months.

2024

2.5 years after complete remission still no signs of disease (NED)

B-cell lymphoma

12 cm lymphoma in the groin

62 years, male

Case study Lukas P.

Early cancer detection prevention & aftercare

Would you like to know if cancer is active in your body? The iPREVENT test enables early detection of minimal tumor entities, which is up to 100x more sensitive than imaging methods. Early detection is ideal for optimal chances of recovery or relapse prevention.

Localized cancer in the early stages

You have just found out that you have an early stage 1 or 2 tumor. You would like to understand as quickly and painlessly as possible what activities your individual tumor is developing and which complementary substances could be used to contain them. Then the iSelect test is right for you!

Cancer in an advanced stage

You are concerned because your tumor has reached stage 3 and 4. It is time to act. In the metastatic stage, it is urgent to act effectively and with few side effects because of the exponential growth. Then the iCOMPLETE test is the right choice.

Breast cancer

You have been diagnosed with breast cancer. Depending on the type, it needs to be treated differently. It is important to understand at an early stage what is driving your individual cancer and how it can be treated effectively and with few side effects.

Prostate cancer

You have been diagnosed with prostate cancer or your PSA level has risen rapidly. You are looking for early and effective treatment options to combat the tumor cells with minimal side effects.

Leukemia/lymphoma/multiple myeloma

You have been diagnosed with a hematologic-oncologic disease. These diseases are diverse and vary from person to person. It is important to understand your specific case in detail in order to find effective therapeutic approaches at an early stage that fight the tumor cells with minimal side effects.

Colorectal cancer

You have been diagnosed with colorectal cancer. Colorectal cancer varies greatly and has individual differences. It is therefore important to analyze your specific case in order to find the best treatment options with minimal side effects.

Lung cancer

You have been diagnosed with lung cancer. Since different types of lung tumors are often difficult to treat and the individual differences between cases can be great, it is crucial to analyze your specific situation in detail.

Skin cancer/ melanoma

You have been diagnosed with skin cancer. Advanced melanomas are often difficult to treat despite modern immunotherapies. It is crucial to gather as much information as possible about your individual tumor at an early stage in order to identify effective treatment options with minimal side effects.

Ovarian cancer

You have been diagnosed with ovarian cancer. In order to find effective therapies with minimal side effects, it is crucial to gather as much information as possible about your tumor at an early stage.

Pancreatic cancer

You have been diagnosed with pancreatic cancer. As pancreatic tumors often progress rapidly and are difficult to treat, it is important to carry out a comprehensive analysis of your individual tumor profile at an early stage. The aim is to find effective therapies with as few side effects as possible.

Stomach cancer

You have been diagnosed with stomach cancer. An early and accurate analysis of your tumor profile is crucial in order to find effective therapies with minimal side effects.

From the watering can principle to individualized treatment

Personalized cancer diagnostics:

Revolution in tumor therapy

Beyond standard therapy

Today’s standard cancer treatment follows guidelines – comparable to a “watering can principle” in which all patients with the same diagnosis are treated similarly. However, modern molecular biological analyses show that Every tumor is unique.

Our individual approach

We identify the specific metabolic pathways and weak points of the individual tumor and develop tailored therapies with approved drugs. Our goal: to find the “Achilles heel” of every tumor.

Why personalization is crucial

Tumors behave like complex systems with their own communication channels, energy supply and protective mechanisms. With conventional treatments, surviving tumor cells often develop resistance by:

  • Actively eject medication
  • Use alternative metabolic routes (such as traffic taking detours during road closures)

Our personalized diagnostics enable more precise, more effective therapies – tailored to each patient.

Liquid Biopsy:

Comprehensive individual cancer diagnostics

Revolution in personalized tumor diagnostics

Our approach includes an in-depth molecular analysis of patients from a liquid biopsy, which opens up new perspectives for you and your doctor: more precise therapy decisions, better treatment outcomes and potentially fewer side effects through customized treatment concepts.

We give you access to personalized medicine that is tailored to the individual characteristics of your tumor – for a better quality of life and new hope in coping with cancer.

Insights into the molecular
signature of your tumor

Determination of gene profiles

Our approach is based on the analysis of gene expression profiles from circulating tumor cells by Liquid Biopsy. Every tumor is unique – that’s why we capture its individual molecular profile to enable tailored therapy options.

Our gene profile analysis offers decisive advantages:

  • Precise identification of active metabolic pathways and signaling cascades in your tumor
  • Early detection of resistance mechanisms before clinical treatment failure
  • Individualized therapy options instead of standardized treatment protocols
  • Painless collection of information through a simple blood sample

Molecular profiling from a painless Liquid Biopsy can detect specific signals in your tumor that conventional methods do not. Based on these signals, your medical team can determine whether certain drugs or therapies could be particularly effective in treating your cancer.

Diagnostics
0 +
Our customer satisfaction
0 /5
Affiliated practices
0

Our satisfied customers

We have helped many patients on their personal journey

Awarded by our patients on Google

Maike Winkelmann

5/5

More clarity and confidence thanks to iQMedix – individual guidance, sound advice, human support
The iQMedix test was a

A real turning point for me. I am living with metastatic breast cancer (including in the lungs, liver and bones) and had water in the pleural cavity on both sides – a situation with a rather poor prognosis. The iQMedix blood test helped me to better tailor my combined therapy (conventional medicine and the Jane McLelland protocol) to my individual tumor.
I was able to get to know the “enemy” better – in other words, find out which factors specifically promote tumor growth. This gave me certainty and a clear strategy.
I was particularly impressed by the expertise and commitment I experienced at iQMedix. My therapist was able to integrate the results directly into my treatment. That was a great support on my journey.
The best moment came with the latest CT results – a real ray of hope: The tumors have receded, the water in the pleural space is completely gone on one side and significantly reduced on the other. No new metastases. And the conspicuous lymph node on the right has completely disappeared.
I am very grateful – and can recommend iQMedix with the utmost conviction.

Gerald Groh

5/5

Very innovative solution for interesting therapy suggestions alongside/parallel to conventional medicine. The

The blood analysis process was wonderfully organized and went very smoothly.

S.R.

5/5

Thanks to the great team at iQMedix!!!!
I would just like to express my gratitude. The entire team was not only top-notch professionally, but also

incredibly warm, understanding and empathetic. I felt safe and in good hands right from the start.

I used to have a conventional biopsy – the pain and anxiety were traumatic for me. So when I found out about the Liquid Biopsy at iQMedix, I was skeptical, but it was a blessing. No pain, no fear, just relief.

It makes me sad that the health insurance companies do not regularly cover this method. You might only get lucky by petitioning the MDK. For me personally, this is the medicine of the future – it should be available to all cancer patients. It would save so much suffering – emotionally and physically – and in the long run it would also save health insurance companies money.

Thank you for being here. You have not only helped me medically, but also given me back a bit of quality of life on my rocky road. 🙏

Hansjoerg Volz

5/5
The iQMedix analysis and the treatment recommendation based on it helped us enormously to safeguard the treatment we were currently undergoing.

Jan Zimmermann

5/5

I was diagnosed with an oesophageal tumor in April 2024 and, thanks to the doctors’ quick response, I was able to

start chemotherapy relatively early. In parallel I was undergoing complementary cancer treatment during which I also learned about iQMedix. Based on the information from a Metavectum Complete Test, I obtained and took the recommended natural remedies.
I have now beaten the cancer and what can I say, the chemo played its part, but I am sure that the complementary treatment and the natural remedies of the iQMedix test were decisive for my healing! Thank you very much, keep up the good work!

Ina Bergeest

5/5

After my cancer diagnosis, I learned about iQMedix and was inspired by a detailed conversation with Dr. Becker

well informed. After a blood test (Metavectum Select), I received a detailed and comprehensive for me very helpful test report.
With the very good informative answers to all my questions, I am finding ways to track down the cancer cells with alternative medical solutions.
The test is definitely a very good and informative method for finding out information about processes in the body. I can only recommend it!
Thank you very much

Rainer Neumann

5/5

My doctor explained to me how iQMedix works and took blood for analysis. I find the approach of iQMedix

exciting and, from my point of view (I’m just a patient), innovative.My doctor explained the very detailed results to me. That was 10 months ago, since then I have been following the suggestions and my condition has stabilized positively. In addition to the conventional medical approaches, the iQMedix approach is amazingly logical and has obviously been effective in my case so far.

Ingrid Müller-Raiser

5/5

A Metavectum iComplete test was carried out on my husband’s blood sample, so he could see which

herbal substances – without side effects – and later chemotherapeutics really helped him. He beat his cancer in a very short time. A thousand thanks to the informed doctor.

Irma Kolic

5/5

Many thanks for the very competent and extremely friendly advice on the blood tests. Dr. Becker provided a detailed and

very informative conversation with me and thanked me for it. start chemotherapy relatively early. In parallel I was undergoing complementary cancer treatment during which I also learned about iQMedix. Based on the information from a Metavectum Complete Test, I obtained and took the recommended natural remedies.
I have now beaten the cancer and what can I say, the chemo played its part, but I am sure that the complementary treatment and the natural remedies of the iQMedix test were decisive for my healing! Thank you very much, keep up the good work!

Dra. Janaiana Koenen

5/5

I am an endocrinologist in Brazil who specializes in the metabolic treatment of cancer.

and I regularly recommend the iQMedix/Metavectum Cancer Blood Test with Gene Expression to my cancer patients as I find it extremely useful in customizing my prescription of supplements and repurposed medications. The test is very thorough and the company provides us with extensive support to understand not only the test but also its full applicability. I can’t wait to make this test available in Brazil for all oncology patients. The staff is very open to discussing the results and advising physicians who are learning about expression testing. So if you are a doctor, do not hesitate and contact them.

Marcus Lamm

5/5

Experienced and helpful staff. Advice was very good and the results in the report were also very good for me.

helpful. I always received competent help with any questions I had. I would order a test there again at any time.

mdsport 999

5/5

Brilliant laboratory with very friendly and competent staff. We have a gene expression test here

with very helpful results. We can recommend this laboratory without reservation!

Dr. Anthony Faro

5/5

As a doctor, I am always on the lookout for reliable laboratories that can help me manage the

support my patients’ complaints. I was recently diagnosed with prostate cancer and began looking for ways to complement and enhance conventional treatments. I was impressed with these tests, so I traveled from the US to Germany to meet the company’s executives and perform the Metavectum Complete Panel on myself.

IQMedix has provided valuable genetic information about my specific cancer and has been helpful in the treatment of my tumor.

I can honestly say that this company is run by good people with good intentions. People who are motivated by the possibilities of helping people and not by money. I am grateful for their help and hospitality and will continue to support their efforts now and in the future. I look forward to offering Metavectum profiles in my office and introducing this technology to my colleagues in the US.

Bader

5/5

I have ordered the iQMedix/Metavectum cancer blood analysis with gene expressions, with the

The aim is to find effective treatments with few side effects that can help replace high-risk treatments with severe side effects that could damage my health and reduce my quality of life or shorten my life if I use them too early.
I was pleased to see that the test revealed several easily accessible supplements that can help me with this project.
It also reassures me that the company does not sell any drugs or products and therefore has no financial stake in its recommendations.
I am satisfied with the uncomplicated blood donation process and the review of the analysis by my doctor.
I will update this review after I have used the newly recommended supplements for a while and collected my own data on their effectiveness.

Gemma Richardson

5/5

iQMedix is a very professional 5-star service. The test was well organized, with clear instructions and

Test results provided within a timely time frame, regardless of whether our blood sample was sent from the UK. We would definitely recommend it to others.

Alexander Ryvkin

5/5

We are very satisfied with this facility! The staff here are highly capable and highly trained specialists who

offer a comprehensive overview of treatment options and their commitment to patient care is highly valued.

First name Last name

5/5

As a doctor, I am always on the lookout for reliable laboratories that can help me manage the

support my patients’ complaints. I was recently diagnosed with prostate cancer and began looking for ways to complement and enhance conventional treatments. I was impressed with these tests, so I traveled from the US to Germany to meet the company’s executives and perform the Metavectum Complete Panel on myself.

IQMedix has provided valuable genetic information about my specific cancer and has been helpful in the treatment of my tumor.

I can honestly say that this company is run by good people with good intentions. People who are motivated by the possibilities of helping people and not by money. I am grateful for their help and hospitality and will continue to support their efforts now and in the future. I look forward to offering Metavectum profiles in my office and introducing this technology to my colleagues in the US.

First name Last name

5/5

I have ordered the iQMedix/Metavectum cancer blood analysis with gene expressions, with the

The aim is to find effective treatments with few side effects that can help replace high-risk treatments with severe side effects that could damage my health and reduce my quality of life or shorten my life if I use them too early.
I was pleased to see that the test revealed several easily accessible supplements that can help me with this project.
It also reassures me that the company does not sell any drugs or products and therefore has no financial stake in its recommendations.
I am satisfied with the uncomplicated blood donation process and the review of the analysis by my doctor.
I will update this review after I have used the newly recommended supplements for a while and collected my own data on their effectiveness.

First name Last name

5/5

iQMedix is a very professional 5-star service. The test was well organized, with clear instructions and

Test results provided within a timely time frame, regardless of whether our blood sample was sent from the UK. We would definitely recommend it to others.

Jp Lem

5/5
IQMedix GmbH has made a real difference for cancer patients. Their advanced tests

offer a comprehensive overview of treatment options and their commitment to patient care is highly valued.

ConTact

e-mail

SOCIAL MEDIA

Our address

iQMedix GmbH
Cubex One
Franz-Volhard-Str. 5
D-68167 Mannheim
Germany

Approach

Reviews

Imprint

Contact & Publisher

iQMedix GmbH
Cubex One
Franz-Volhard-Str. 5
D-68167 Mannheim

Phone: +49 (0)621 5957 0500
E-mail: info@iQMedix.eu

HRB 751295
Local Court Mannheim
UST-ID: DE363027900

Authorized representatives

Managing Director:

Dr. Bert Steffan
E-Mail: Bert.Steffan@iQMedix.eu

Dr. Bernd Becker
E-Mail: Bernd.Becker@iQMedix.eu

Dr. Reinhard Becker
E-Mail: Reinhard.Becker@iQMedix.eu


Information on online dispute resolution pursuant to Art. 14 para. 1 ODR-VO

The European Commission provides a platform for online dispute resolution (OS), which you can find at https://ec.europa.eu/consumers/odr/.
Our email address is: info@iQMedix.eu

Information on consumer dispute resolution in accordance with § 36 VSBG
We will not participate in a dispute resolution procedure before a consumer arbitration board within the meaning of the Consumer Dispute Resolution Act and are not obliged to do so.
Nevertheless, we endeavor to settle any disputes arising from consumer contracts out of court. Please contact us.
Liability for content

As a service provider, we are responsible for our own content on these pages in accordance with Section 7 (1) TMG (German Telemedia Act) and general legislation. According to §§ 8 to 10 TMG, however, we as a service provider are not obliged to monitor transmitted or stored third-party information or to investigate circumstances that indicate illegal activity. Obligations to remove or block the use of information in accordance with general legislation remain unaffected by this. However, liability in this respect is only possible from the time of knowledge of a specific infringement. As soon as we become aware of such infringements, we will remove this content immediately.

Liability for links

Our website contains links to external third-party websites over whose content we have no influence. Therefore, we cannot accept any liability for this third-party content. The respective provider or operator of the pages is always responsible for the content of the linked pages. The linked pages were checked for possible legal violations at the time of linking. Illegal content was not recognizable at the time of linking. However, permanent monitoring of the content of the linked pages is not reasonable without concrete evidence of an infringement. If we become aware of any legal infringements, we will remove such links immediately.

Copyright

The content and works created by the site operators on these pages are subject to German copyright law. Duplication, processing, distribution and any form of commercialization of such material beyond the scope of the copyright law shall require the prior written consent of its respective author or creator. Downloads and copies of this site are only permitted for private, non-commercial use. Insofar as the content on this site was not created by the operator, the copyrights of third parties are respected. In particular, third-party content is identified as such. Should you nevertheless become aware of a copyright infringement, please inform us accordingly. If we become aware of any infringements, we will remove such content immediately.

The use of content, graphics and the corporate design, even in part, is not permitted. Concept, design, realization: iQMedix

Picture credits:

  • iQMedix
  • Adobe Stock (licensed content)
  • AI-generated images created with Grok

Typography
This website uses the following font:

  • Inter

Data protection

1. definitions

The data protection declaration of the iQMedix GmbH is based on the terms used by the European legislator for the adoption of the General Data Protection Regulation (GDPR). Our privacy policy should be easy to read and understand for the public as well as for our customers and business partners. To ensure this, we would like to explain the terms used in advance.

We use the following terms, among others, in this privacy policy:

a) personal data

Personal data means any information relating to an identified or identifiable natural person (hereinafter referred to as “data subject”). An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as a name, an identification number, location data, an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person.

b) Person concerned

Data subject is any identified or identifiable natural person whose personal data is processed by the controller responsible for the processing.

c) Processing

Processing is any operation or set of operations which is performed on personal data or on sets of personal data, whether or not by automated means, such as collection, recording, organization, structuring, storage, adaptation or alteration, retrieval, consultation, use, disclosure by transmission, dissemination or otherwise making available, alignment or combination, restriction, erasure or destruction.

d) Restriction of processing

Restriction of processing is the marking of stored personal data with the aim of restricting its future processing.

e) Profiling

Profiling means any form of automated processing of personal data consisting of the use of personal data to evaluate certain personal aspects relating to a natural person, in particular to analyze or predict aspects concerning that natural person’s performance at work, economic situation, health, personal preferences, interests, reliability, behavior, location or movements.

f) Pseudonymization

Pseudonymization is the processing of personal data in such a manner that the personal data can no longer be attributed to a specific data subject without the use of additional information, provided that such additional information is kept separately and is subject to technical and organizational measures to ensure that the personal data are not attributed to an identified or identifiable natural person.

g) Controller or controller responsible for the processing

Controller or controller responsible for the processing is the natural or legal person, public authority, agency or other body which, alone or jointly with others, determines the purposes and means of the processing of personal data. Where the purposes and means of such processing are determined by Union or Member State law, the controller or the specific criteria for its nomination may be provided for by Union or Member State law.

h) Processor

Processor is a natural or legal person, public authority, agency or other body which processes personal data on behalf of the controller.

i) Recipient

Recipient is a natural or legal person, public authority, agency or another body, to which the personal data are disclosed, whether a third party or not. However, public authorities which may receive personal data in the framework of a particular inquiry in accordance with Union or Member State law shall not be regarded as recipients.

j) Third party

Third party is a natural or legal person, public authority, agency or body other than the data subject, controller, processor and persons who, under the direct authority of the controller or processor, are authorized to process personal data.

k) Consent

Consent is any freely given, specific, informed and unambiguous indication of the data subject’s wishes by which he or she, by a statement or by a clear affirmative action, signifies agreement to the processing of personal data relating to him or her.

2. name and address of the controller

The controller within the meaning of the General Data Protection Regulation, other data protection laws applicable in the Member States of the European Union and other provisions of a data protection nature is the:

iQMedix GmbH
Cubex One
Franz-Volhard-Str. 5
68167 Mannheim
Germany
Phone: +49 (0)621 5957 0991
E-mail: info@iQMedix.eu
Website: www.iQMedix.eu

3. name and address of the data protection officer

The data protection officer of the controller is

Dr. Bernd Becker
iQMedix GmbH
Cubex One
Franz-Volhard-Str. 5
68167 Mannheim
Germany
Phone: +49 (0)621 5957 0991
E-mail: datenschutz@iQMedix.eu
Website: www.iQMedix.eu

You can contact our data protection officer directly if you have any questions or concerns about data protection.

4. cookies and services used

The Internet pages of the iQMedix GmbH use cookies. Cookies are text files that are placed and stored on a computer system via an Internet browser.

Numerous websites and servers use cookies. Many cookies contain a so-called cookie ID. A cookie ID is a unique identifier for the cookie. It consists of a string of characters through which websites and servers can be assigned to the specific internet browser in which the cookie was stored. This enables the websites and servers visited to distinguish the individual browser of the data subject from other Internet browsers that contain other cookies. A specific Internet browser can be recognized and identified via the unique cookie ID.

Through the use of cookies, the iQMedix GmbH can provide the users of this website with more user-friendly services that would not be possible without the cookie setting.

By means of a cookie, the information and offers on our website can be optimized for the benefit of the user. As already mentioned, cookies enable us to recognize the users of our website. The purpose of this recognition is to make it easier for users to use our website.

You can prevent the setting of cookies by our website at any time by means of a corresponding setting of the Internet browser used and thus permanently object to the setting of cookies. Furthermore, cookies that have already been set can be deleted at any time via an Internet browser or other software programs. This is possible in all common Internet browsers. If the data subject deactivates the setting of cookies in the Internet browser used, not all functions of our website may be fully usable.

WordPress and Elementor Pro

This website is managed with the WordPress content management system and the Elementor Pro theme/editor. These can generate cookies to improve the functionality and user-friendliness of the website. Cookies are stored on your computer by your web browser in the form of small text files. Cookies are harmless in terms of data protection and security. No personal information is stored in cookies, and the content cannot be read or used elsewhere. Almost all browsers accept cookies by default. If you do not wish to accept cookies, please change your browser settings accordingly. Please note that the full functionality of the website will no longer be available.

Privacy policy of WordPress: https://wordpress.org/about/privacy/

Privacy policy of Elementor: https://elementor.com/about/privacy/

Google Maps

This website uses the Google Maps map service via an API. The provider is Google LLC, 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA. To use the functions of Google Maps, it is necessary to save your IP address. This information is usually transmitted to a Google server in the USA and stored there. The provider of this site has no influence on this data transfer. The use of Google Maps is in the interest of an appealing presentation of our online offers and to make it easy to find the places we have indicated on the website. This constitutes a legitimate interest within the meaning of Art. 6 para. 1 lit. f GDPR. You can find more information on the handling of user data in Google’s privacy policy: https://www.google.de/intl/de/policies/privacy

Google Web Fonts

This website uses so-called web fonts provided by Google for the uniform display of fonts. We use the Google font “Inter”. When you access a page, your browser loads the required web fonts into your browser cache in order to display texts and fonts correctly. For this purpose, the browser you are using must connect to Google’s servers. This informs Google that our website has been accessed via your IP address. The use of Google Web Fonts is in the interest of a uniform and appealing presentation of our online offers. This constitutes a legitimate interest within the meaning of Art. 6 para. 1 lit. f GDPR. If your browser does not support web fonts, a standard font will be used by your computer. Further information on Google Web Fonts can be found at https://developers.google.com/fonts/faq and in Google’s privacy policy: https://www.google.com/policies/privacy/

YouTube

Our website uses plugins from the Google-operated YouTube site. The operator of the pages is Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland. When you visit one of our pages equipped with a YouTube plugin, a connection to the YouTube servers is established. The YouTube server is informed which of our pages you have visited. If you are logged into your YouTube account, you enable YouTube to assign your surfing behavior directly to your personal profile. You can prevent this by logging out of your YouTube account. The use of YouTube is in the interest of an appealing presentation of our online offers. This constitutes a legitimate interest within the meaning of Art. 6 para. 1 lit. f GDPR. Further information on the handling of user data can be found in YouTube’s privacy policy at: https://www.google.de/intl/de/policies/privacy

Contact form (Wufoo from SurveyMonkey) and Klick-Tipp

If you contact us via our contact form, we use the Wufoo service from SurveyMonkey (SurveyMonkey Inc., One Curiosity Way, San Mateo, CA 94403, USA). Wufoo is a tool for creating forms that collects the data you enter and transmits it to us.

The data collected via the contact form is also forwarded to the marketing automation software Klick-Tipp (KLICK-TIPP LIMITED, 15 Cambridge Court, 210 Shepherd’s Bush Road, London W6 7NJ, United Kingdom). Klick-Tipp is a service with which the sending of newsletters can be organized and analyzed. The data you enter for the purpose of subscribing to the newsletter is stored on Klick-Tipp’s servers. If you do not wish to be analyzed by Klick-Tipp, you must unsubscribe from the newsletter. We provide a corresponding link for this purpose in every newsletter message.

With the help of Klick-Tipp, we can also analyze whether and when our newsletters are opened by you and which links you click on in them. Klick-Tipp also enables us to classify newsletter recipients according to various categories (e.g. according to areas of interest). This allows the newsletters to be better adapted to the respective interests of the recipients.

The data you enter in the contact form will be stored by us for the purpose of processing your request and in the event of follow-up questions. We will not pass on this data without your consent.

The data entered in the contact form is processed exclusively on the basis of your consent (Art. 6 para. 1 lit. a GDPR). You can revoke this consent at any time. All you need to do is send us an informal email. The legality of the data processing operations carried out until the revocation remains unaffected by the revocation.

We will retain the data you provide on the contact form until you request its deletion, revoke your consent for its storage, or the purpose for its storage no longer pertains (e.g. after fulfilling your request). Mandatory statutory provisions – in particular retention periods – remain unaffected.

Further information about Wufoo by SurveyMonkey can be found in SurveyMonkey’s privacy policy: https://www.surveymonkey.com/mp/legal/privacy-policy/

Further information about Klick-Tipp can be found in Klick-Tipp’s privacy policy: https://www.klick-tipp.com/datenschutzerklaerung

Google reCAPTCHA

We use “Google reCAPTCHA” (hereinafter “reCAPTCHA”) in connection with our contact form. The provider is Google LLC, 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA (“Google”). The purpose of reCAPTCHA is to check whether the data input on our website (e.g. in a contact form) is made by a human or by an automated program. For this purpose, reCAPTCHA analyzes the behavior of the website visitor based on various characteristics. This analysis begins automatically as soon as the website visitor accesses the contact form. For the analysis, reCAPTCHA evaluates various information (e.g. IP address, time spent on the website by the website visitor or mouse movements made by the user). The data collected during the analysis is forwarded to Google. The reCAPTCHA analyses run completely in the background. Website visitors are not informed that an analysis is taking place. Data processing is carried out on the basis of Art. 6 para. 1 lit. f GDPR. The website operator has a legitimate interest in protecting its website from abusive automated spying and SPAM. Further information about Google reCAPTCHA and Google’s privacy policy can be found at the following links: https://www.google.com/intl/de/policies/privacy/ and https://www.google.com/recaptcha/intro/android.html.

Google Site Kit

We use the WordPress plugin Google Site Kit on our website, which bundles various Google services. The provider is Google LLC, 1600 Amphitheatre Parkway, Mountain View, CA 94043, USA.

With Google Site Kit, we can view statistics on visitor numbers, popular pages and traffic sources, among other things. The plugin can integrate the following Google services: Google Analytics (statistics on visitor numbers), Search Console (analysis of search results), AdSense (integration of advertisements), PageSpeed Insights (analysis of loading speed), Tag Manager (management of tags) and Optimize (website optimization).

When you use Google Site Kit, data such as your IP address, the browser you are using, your operating system, the page you visited previously, your surfing behavior on our website and the date and time of your visit are transmitted to Google servers and stored there. This transfer usually takes place in the USA. We have no direct influence on the data collected and its processing by Google.

The use of Google Site Kit is based on our legitimate interest in a user-friendly design and the statistical evaluation of our website in accordance with Art. 6 para. 1 lit. f GDPR.

You can prevent the collection and processing of your data by Google by deactivating the execution of script code in your browser, installing a script blocker or activating the “Do Not Track” setting in your browser.

Further information on data protection at Google Site Kit can be found here: https://sitekit.withgoogle.com/service-terms/ and in Google’s privacy policy: https://policies.google.com/privacy

Google Analytics

This website uses functions of the web analysis service Google Analytics. The provider is Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland.

Google Analytics uses so-called “cookies”. These are text files that are stored on your computer and enable your use of the website to be analyzed. The information generated by the cookie about your use of this website is usually transmitted to a Google server in the USA and stored there.

The storage of Google Analytics cookies and the use of this analysis tool are based on Art. 6 para. 1 lit. f GDPR. The website operator has a legitimate interest in the analysis of user behavior in order to optimize both its website and its advertising.

We have concluded an order processing contract with Google and fully implement the strict requirements of the German data protection authorities when using Google Analytics.

IP anonymization

We have activated the IP anonymization function on this website. This means that your IP address will be shortened by Google within member states of the European Union or in other contracting states of the Agreement on the European Economic Area before being transmitted to the USA. Only in exceptional cases will the full IP address be transmitted to a Google server in the USA and shortened there. Google will use this information on behalf of the operator of this website for the purpose of evaluating your use of the website, compiling reports on website activity and providing other services relating to website activity and internet usage to the website operator. The IP address transmitted by your browser as part of Google Analytics will not be merged with other Google data.

Browser plugin

You may refuse the use of cookies by selecting the appropriate settings on your browser, however please note that if you do this you may not be able to use the full functionality of this website. You can also prevent Google from collecting the data generated by the cookie and relating to your use of the website (including your IP address) and from processing this data by Google by downloading and installing the browser plug-in: https://tools.google.com/dlpage/gaoptout?hl=de

Objection to data collection

You can prevent the collection of your data by Google Analytics by clicking on the following link. An opt-out cookie will be set to prevent your data from being collected on future visits to this website: Deactivate Google Analytics.

You can find more information on how Google Analytics handles user data in Google’s privacy policy: https://support.google.com/analytics/answer/6004245?hl=de

Wordfence security plugin

This website is secured with the “Wordfence Security” service, which is operated by Defiant Inc, 800 5th Ave, Suite 4100, Seattle, WA 98104, USA. The use is based on the legitimate interest within the meaning of Art. 6 para. 1 lit. f GDPR. The website uses Wordfence Security to protect against malicious code and to defend against attacks by criminals. The plugin is configured so that no cookies are set on the user’s computer. For the purpose of protection against so-called brute force attacks (numerous automated login attempts from the same identity) or unauthorized access to the web server or the database, the IP addresses (exclusively) from which such attempts are made are stored locally on our web server. This enables repeated attempts to attack from the same IP to be warded off more effectively. Stored IP addresses are automatically deleted after 30 days. The data is only stored locally; no data is sent to external service providers, in particular the aforementioned Defiant Inc. Wordfence Security secures this website and thus also protects visitors to the website from viruses and malware. This constitutes a legitimate interest within the meaning of the GDPR. The Live Traffic View option (real-time live traffic) of the plug-in is reduced to security-relevant listings. Further information on the collection and use of data by Wordfence Security can be found in the provider’s privacy policy: https://www.wordfence.com/privacy-policy/, https://www.wordfence.com/help/general-data-protection-regulation/.

5. social media presence
Our presence on social networks and platforms

We maintain online presences within social networks and platforms in order to communicate with the customers, interested parties and users active there and to be able to inform them about our services. When accessing the respective networks and platforms, the terms and conditions and data processing guidelines of the respective operators apply.

Unless otherwise stated in our privacy policy, we process users’ data if they communicate with us within the social networks and platforms, e.g. write posts on our online presences or send us messages.

Facebook

We have a profile on Facebook. The provider is Meta Platforms Ireland Limited, 4 Grand Canal Square, Grand Canal Harbour, Dublin 2, Ireland. Facebook is certified in accordance with the EU-US Privacy Shield.

We have concluded a joint processing agreement (Controller Addendum) with Facebook. This agreement specifies which data processing operations we or Facebook are responsible for when you visit our Facebook page.

You can adjust the settings for advertisements in Facebook in your user profile yourself: https://www.facebook.com/ads/preferences/

By using Facebook, your data may be stored and processed on servers in the USA. For details on the processing activities, their objection options and the deletion of data by Facebook, please refer to Facebook’s privacy policy: https://www.facebook.com/about/privacy/

Twitter

We use the short message service Twitter. The provider is Twitter International Company, One Cumberland Place, Fenian Street, Dublin 2, D02 AX07, Ireland.

You can find Twitter’s privacy policy at: https://twitter.com/de/privacy

By using Twitter, your data may be stored and processed on servers in the USA. You can change your Twitter privacy settings yourself in your user account.

Instagram

We have a presence on Instagram. The provider is Meta Platforms Ireland Limited, 4 Grand Canal Square, Grand Canal Harbour, Dublin 2, Ireland.

Our Instagram page is jointly responsible for processing your data with Meta Platforms Ireland. For details on joint processing and the options to restrict it, please refer to Instagram’s privacy policy: https://help.instagram.com/519522125107875

You can find Instagram’s privacy policy at: https://help.instagram.com/196883487377501

By using Instagram, your data may be stored and processed on servers in the USA. The data processing takes place on the basis of an agreement on joint processing in accordance with Art. 26 GDPR.

Note on data transfer to the USA

When using social media, data may be transferred to the USA. We would like to point out that, in the opinion of the European Court of Justice, there is no adequate level of data protection in the USA and that data processing by US services entails the risk that US authorities may be able to access this data without you having sufficient legal remedies.

We only use these services if you have expressly given us your consent to do so (Art. 49 para. 1 sentence 1 lit. a GDPR) or if there is a legitimate interest within the meaning of Art. 6 para. 1 lit. f GDPR, such as the possibility of being able to present our offers to a wider public.

6. collection of general data and information

The website of the iQMedix GmbH collects a series of general data and information when a data subject or automated system calls up the website. This general data and information is stored in the server log files. The (1) browser types and versions used, (2) the operating system used by the accessing system, (3) the website from which an accessing system accesses our website (so-called referrer), (4) the sub-websites which are accessed via an accessing system on our website can be recorded, (5) the date and time of access to the website, (6) an internet protocol address (IP address), (7) the internet service provider of the accessing system and (8) other similar data and information used for security purposes in the event of attacks on our information technology systems.

When using these general data and information, the iQMedix GmbH does not draw any conclusions about the data subject. Rather, this information is needed to (1) deliver the content of our website correctly, (2) optimize the content of our website as well as its advertisement, (3) ensure the long-term viability of our information technology systems and website technology, and (4) provide law enforcement authorities with the information necessary for criminal prosecution in case of a cyber-attack. Therefore, the iQMedix GmbH analyzes anonymously collected data and information statistically, with the aim of increasing the data protection and data security of our enterprise, and to ensure an optimal level of protection for the personal data we process. The anonymous data of the server log files are stored separately from all personal data provided by a data subject.

7. contact possibility via the website

The website of the iQMedix GmbH contains information that enables a quick electronic contact to our enterprise, as well as direct communication with us, which also includes a general address of the so-called electronic mail (e-mail address). If a data subject contacts the controller by email or via a contact form, the personal data transmitted by the data subject is automatically stored. Such personal data transmitted on a voluntary basis by a data subject to the controller are stored for the purposes of processing or contacting the data subject. This personal data is not passed on to third parties.

8. special provisions on the processing of health data

iQMedix GmbH also processes health data as part of its services. Health data belong to the special categories of personal data pursuant to Art. 9 GDPR and enjoy special protection.

8.1 Type of health data processed

We may process the following types of health data as part of our services:

Information on diseases, diagnoses and therapies
Laboratory findings and analysis results
Medical reports and expert opinions
Other health-related information required for our services
8.2 Purpose of processing health data

Health data is processed exclusively for the following purposes:

Provision of our medical services
Preparation of analyses and findings
Advice on medical matters
Administration and organization of patient care
Compliance with statutory retention obligations
8.3 Legal basis for the processing of health data

The processing of health data is generally based on explicit consent in accordance with Art. 9 para. 2 lit. a GDPR. In certain cases, processing may also be based on other legal grounds, such as

for the purposes of preventive healthcare or occupational medicine pursuant to Art. 9 para. 2 lit. h GDPR
if processing is necessary for reasons of public interest in the area of public health pursuant to Art. 9 para. 2 lit. i GDPR
if processing is necessary for the establishment, exercise or defense of legal claims pursuant to Art. 9 para. 2 lit. f GDPR
8.4 Special protective measures for health data

Due to the particular sensitivity of health data, we have implemented additional technical and organizational measures to ensure adequate protection of this data:

Encryption during transmission and storage
Strict access controls and access rights
Regular training of our employees on handling sensitive data
Special premises and systems for processing health data
Regular review and updating of our security measures
9. Routine deletion and blocking of personal data

The controller shall process and store the personal data of the data subject only for the period necessary to achieve the purpose of storage, or as far as this is granted by the European legislator or other legislators in laws or regulations to which the controller is subject to.

If the storage purpose no longer applies or if a storage period prescribed by the European legislator or another competent legislator expires, the personal data will be routinely blocked or deleted in accordance with the statutory provisions.

10. rights of the data subject
a) Right to confirmation

Each data subject shall have the right granted by the European legislator to obtain from the controller the confirmation as to whether or not personal data concerning him or her are being processed. If a data subject wishes to avail himself of this right of confirmation, he or she may, at any time, contact our Data Protection Officer or another employee of the controller.

b) Right to information

Any person affected by the processing of personal data has the right, granted by the European legislator of directives and regulations, to obtain from the controller free information about the personal data stored about him/her and a copy of this information at any time. Furthermore, the European legislator has granted the data subject access to the following information:

the purposes of processing
the categories of personal data that are processed
the recipients or categories of recipients to whom the personal data have been or will be disclosed, in particular recipients in third countries or international organizations
where possible, the envisaged period for which the personal data will be stored, or, if not possible, the criteria used to determine that period
the existence of the right to request from the controller rectification or erasure of personal data or restriction of processing of personal data concerning the data subject or to object to such processing
the existence of a right to lodge a complaint with a supervisory authority
if the personal data is not collected from the data subject: All available information about the origin of the data
the existence of automated decision-making, including profiling, referred to in Article 22(1) and (4) GDPR and, at least in those cases, meaningful information about the logic involved, as well as the significance and the envisaged consequences of such processing for the data subject

Furthermore, the data subject has a right to information as to whether personal data has been transferred to a third country or to an international organization. If this is the case, the data subject also has the right to obtain information about the appropriate safeguards in connection with the transfer.

If a data subject wishes to avail himself of this right of access, he or she may at any time contact our Data Protection Officer or another employee of the controller.

c) Right to rectification

Any person affected by the processing of personal data has the right granted by the European legislator of directives and regulations to demand the immediate correction of incorrect personal data concerning them. Taking into account the purposes of the processing, the data subject shall also have the right to have incomplete personal data completed, including by means of providing a supplementary statement.

If a data subject wishes to exercise this right to rectification, he or she may, at any time, contact our Data Protection Officer or another employee of the controller.

d) Right to erasure (right to be forgotten)

Each data subject shall have the right granted by the European legislator to obtain from the controller the erasure of personal data concerning him or her without undue delay, and the controller shall have the obligation to erase personal data without undue delay where one of the following grounds applies, as long as the processing is not necessary

The personal data have been collected or otherwise processed for purposes for which they are no longer necessary.
The data subject withdraws consent on which the processing is based according to point (a) of Article 6(1) of the GDPR, or point (a) of Article 9(2) of the GDPR, and where there is no other legal ground for the processing.
The data subject objects to the processing pursuant to Article 21(1) of the GDPR and there are no overriding legitimate grounds for the processing, or the data subject objects to the processing pursuant to Article 21(2) of the GDPR. 21 (2) GDPR objects to the processing.
The personal data have been unlawfully processed.
The personal data have to be erased for compliance with a legal obligation in Union or Member State law to which the controller is subject.
The personal data have been collected in relation to the offer of information society services referred to in Art. 8 (1) GDPR.

If one of the aforementioned reasons applies, and a data subject wishes to request the erasure of personal data stored by the iQMedix GmbH, he or she may at any time contact our Data Protection Officer or another employee of the controller. The Data Protection Officer of the iQMedix GmbH or another employee shall promptly ensure that the erasure request is complied with immediately.

If the personal data has been made public by iQMedix GmbH and if our company is obliged to delete the personal data in accordance with Art. 17 para. 1 GDPR, iQMedix GmbH shall take appropriate measures, including technical measures, taking into account the available technology and the implementation costs, to inform other data controllers who process the published personal data, that the data subject has requested the deletion of all links to this personal data or of copies or replications of this personal data from these other data controllers, insofar as the processing is not necessary. The Data Protection Officer of the iQMedix GmbH or another employee will arrange the necessary measures in individual cases.

e) Right to restriction of processing

Each data subject shall have the right granted by the European legislator to obtain from the controller restriction of processing where one of the following applies:

The accuracy of the personal data is contested by the data subject, for a period enabling the controller to verify the accuracy of the personal data.
The processing is unlawful and the data subject opposes the erasure of the personal data and requests the restriction of their use instead.
The controller no longer needs the personal data for the purposes of the processing, but they are required by the data subject for the establishment, exercise or defense of legal claims.
The data subject has objected to processing pursuant to Article 21(1) of the GDPR pending the verification whether the legitimate grounds of the controller override those of the data subject.

If one of the aforementioned conditions is met, and a data subject wishes to request the restriction of the processing of personal data stored by the iQMedix GmbH, he or she may at any time contact our Data Protection Officer or another employee of the controller. The Data Protection Officer of the iQMedix GmbH or another employee will arrange the restriction of the processing.

f) Right to data portability

Any person affected by the processing of personal data has the right, granted by the European legislator, to receive the personal data concerning him or her, which he or she has provided to a controller, in a structured, commonly used and machine-readable format. He or she also has the right to transmit those data to another controller without hindrance from the controller to which the personal data have been provided, where the processing is based on consent pursuant to point (a) of Article 6(1) of the GDPR or point (a) of Article 9(2) of the GDPR or on a contract pursuant to point (b) of Article 6(1) of the GDPR and the processing is carried out by automated means, provided that the processing is not necessary for the performance of a task carried out in the public interest or in the exercise of official authority vested in the controller.

Furthermore, in exercising their right to data portability pursuant to Art. 20 (1) GDPR, the data subject has the right to have the personal data transmitted directly from one controller to another, where technically feasible and provided that this does not adversely affect the rights and freedoms of others.

In order to assert the right to data portability, the data subject may at any time contact the Data Protection Officer designated by the iQMedix GmbH or another employee.

g) Right to object

Any person affected by the processing of personal data has the right granted by the European legislator to object, on grounds relating to his or her particular situation, at any time to processing of personal data concerning him or her which is based on point (e) or (f) of Article 6(1) of the GDPR. This also applies to profiling based on these provisions.

The iQMedix GmbH shall no longer process the personal data in the event of the objection, unless we can demonstrate compelling legitimate grounds for the processing which override the interests, rights and freedoms of the data subject, or for the establishment, exercise or defense of legal claims.

If the iQMedix GmbH processes personal data for direct marketing purposes, the data subject shall have the right to object at any time to processing of personal data concerning him or her for such marketing. This also applies to profiling insofar as it is associated with such direct advertising. If the data subject objects to the iQMedix GmbH to the processing for direct marketing purposes, the iQMedix GmbH will no longer process the personal data for these purposes.

In addition, the data subject has the right, on grounds relating to his or her particular situation, to object to processing of personal data concerning him or her by the iQMedix GmbH for scientific or historical research purposes, or for statistical purposes pursuant to Article 89(1) of the GDPR, unless the processing is necessary for the performance of a task carried out for reasons of public interest.

In order to exercise the right to object, the data subject may directly contact the Data Protection Officer of the iQMedix GmbH or another employee. The data subject is also free, in the context of the use of information society services, and notwithstanding Directive 2002/58/EC, to exercise his or her right to object by automated means using technical specifications.

h) Automated decisions in individual cases including profiling

Each data subject shall have the right granted by the European legislator not to be subject to a decision based solely on automated processing, including profiling, which produces legal effects concerning him or her, or similarly significantly affects him or her, provided that the decision (1) is not necessary for the conclusion or performance of a contract between the data subject and the controller, or (2) is authorized by Union or Member State law to which the controller is subject and which also lays down suitable measures to safeguard the data subject’s rights and freedoms and legitimate interests, or (3) is based on the data subject’s explicit consent.

If the decision (1) is necessary for entering into, or the performance of, a contract between the data subject and a data controller, or (2) it is based on the data subject’s explicit consent, the iQMedix GmbH shall implement suitable measures to safeguard the data subject’s rights and freedoms and legitimate interests, at least the right to obtain human intervention on the part of the controller, to express his or her point of view and contest the decision.

If the data subject wishes to exercise the rights concerning automated individual decision-making, he or she may, at any time, contact our Data Protection Officer or another employee of the controller.

i) Right to withdraw consent under data protection law

Any person affected by the processing of personal data has the right granted by the European legislator to withdraw consent to the processing of personal data at any time.

If the data subject wishes to exercise their right to withdraw consent, they can contact our data protection officer or another employee of the controller at any time.

11. data protection for applications and in the application process

The controller collects and processes the personal data of applicants for the purpose of handling the application process. Processing may also be carried out electronically. This is particularly the case if an applicant submits relevant application documents to the controller by electronic means, for example by email or via a web form on the website. If the controller concludes an employment contract with an applicant, the transmitted data will be stored for the purpose of processing the employment relationship in compliance with the statutory provisions. If the controller does not conclude an employment contract with the applicant, the application documents will be automatically deleted two months after notification of the rejection decision, provided that no other legitimate interests of the controller stand in the way of deletion. Other legitimate interest in this sense is, for example, a burden of proof in proceedings under the General Equal Treatment Act (AGG).

12. legal basis of the processing

Art. 6 I lit. a GDPR serves our company as the legal basis for processing operations for which we obtain consent for a specific processing purpose. If the processing of personal data is necessary for the performance of a contract to which the data subject is party, as is the case, for example, when processing operations are necessary for the supply of goods or to provide any other service or consideration, the processing is based on Art. 6 I lit. b GDPR. The same applies to such processing operations that are necessary to carry out pre-contractual measures, for example in cases of inquiries about our products or services. If our company is subject to a legal obligation which requires the processing of personal data, such as for the fulfillment of tax obligations, the processing is based on Art. 6 I lit. c GDPR. In rare cases, the processing of personal data may become necessary in order to protect the vital interests of the data subject or another natural person. This would be the case, for example, if a visitor were injured in our company and their name, age, health insurance data or other vital information would have to be passed on to a doctor, hospital or other third party. The processing would then be based on Art. 6 I lit. d GDPR. Ultimately, processing operations could be based on Art. 6 I lit. f GDPR. Processing operations that are not covered by any of the aforementioned legal bases are based on this legal basis if the processing is necessary to safeguard a legitimate interest of our company or a third party, provided that the interests, fundamental rights and freedoms of the data subject do not prevail. We are permitted to carry out such processing operations in particular because they have been specifically mentioned by the European legislator. In this respect, it took the view that a legitimate interest could be assumed if the data subject is a customer of the controller (Recital 47 Sentence 2 GDPR).

13. legitimate interests in the processing pursued by the controller or a third party

Where the processing of personal data is based on Article 6 I lit. f GDPR, our legitimate interest is the performance of our business activities for the benefit of the well-being of all our employees and our shareholders.

14. duration for which the personal data is stored

The criterion for the duration of the storage of personal data is the respective statutory retention period. After this period has expired, the corresponding data is routinely deleted, provided that it is no longer required for contract fulfillment or contract initiation.

15. legal or contractual provisions for the provision of personal data; necessity for the conclusion of the contract; obligation of the data subject to provide the personal data; possible consequences of non-provision

We would like to inform you that the provision of personal data is partly required by law (e.g. tax regulations) or may also result from contractual regulations (e.g. information on the contractual partner). Sometimes it may be necessary for a contract to be concluded for a data subject to provide us with personal data that must subsequently be processed by us. For example, the data subject is obliged to provide us with personal data if our company concludes a contract with them. Failure to provide the personal data would mean that the contract with the data subject could not be concluded. Before the data subject provides personal data, the data subject must contact our data protection officer. Our data protection officer will inform the data subject on a case-by-case basis whether the provision of the personal data is required by law or contract or is necessary for the conclusion of the contract, whether there is an obligation to provide the personal data and what the consequences would be if the personal data were not provided.

16. existence of automated decision-making

As a responsible company, we do not use automated decision-making or profiling.

17. right of appeal

If you believe that we have infringed the GDPR when processing personal data concerning you, you may lodge a complaint with a supervisory authority, in particular in the Member State of your habitual residence, place of work or place of the alleged infringement, which will examine your complaint.

The competent lead supervisory authority for data protection pursuant to Art. 56 GDPR in the event of complaints is

The State Commissioner for Data Protection and Freedom of Information Baden-Württemberg
P.O. Box 10 29 32
70025 Stuttgart
Tel.: 0711/61 55 41 – 0
E-mail: poststelle@lfdi.bwl.de


Cookie Policy

Introduction
Our website, www.iQMedix.eu (hereinafter: “the website”), uses cookies and other related technologies (for convenience all technologies are referred to as “cookies”). Cookies are also placed by third parties commissioned by us. In the following document we inform you about the use of cookies on our website.

What are cookies?
A cookie is a simple small file that is sent together with the pages of an Internet address and can be stored by the web browser on the PC or another device. The information stored in it can be sent to our servers or the servers of relevant third-party providers during subsequent visits.

What are scripts?
A script is a piece of program code that is used to make our website functional and interactive. This code is executed on our servers or on your device.

What is a web beacon?
A web beacon (also called a pixel tag) is a small invisible fragment of text or image on a website that is used to monitor traffic on the website. To make this possible, various data about you is stored using web beacons.

Cookies
Technical or functional cookies
Some cookies ensure that parts of our website function properly and that your user preferences remain known. By placing functional cookies, we make it easier for you to visit our website. This way, you do not have to repeatedly enter the same information when you visit our website. We can place these cookies without your permission.

The technical and functional cookies that we use include

WordPress cookies for the basic functionality of the website
Elementor Pro cookies for the proper display of the website
Wordfence Security cookies to protect the website from attacks
Analytical cookies
We use analytical cookies to optimize the website experience for our users. With these analytical cookies we gain insight into the use of our website. We ask for your permission to place analytical cookies.

The analytical cookies that we use include

Google Analytics cookies to analyze visitor and usage data
Google Site Kit cookies to obtain statistics on visitor numbers, popular pages and traffic sources
Marketing/tracking cookies
Marketing/tracking cookies are cookies or other forms of local storage used to create user profiles in order to display advertising or track the user on this website or across multiple websites for similar marketing purposes.

The marketing/tracking cookies we use include:

Google Maps cookies for displaying map information
YouTube cookies for displaying videos
Cookies for integrating our social media presences (Facebook, Twitter, Instagram)
Klick-Tipp cookies for analyzing newsletter openings and click behavior
Third-party cookies
Our website uses various third-party services that may also set cookies:

Google Services: Google Maps, Google Web Fonts, Google Analytics, Google Site Kit, YouTube, Google reCAPTCHA
Social media platforms: Facebook (Meta), Twitter, Instagram
Forms: Wufoo by SurveyMonkey
Newsletter: Klick-Tipp
Security: Wordfence Security
Consent
When you visit our website for the first time, we show you a pop-up with an explanation about cookies. As soon as you click on “Save settings”, you give us your consent to use all the categories of cookies and plug-ins you have selected as described in this cookie statement. You can deactivate the use of cookies via your browser, but please note that our website may then not function properly.

Activating/deactivating and deleting cookies
You can use your internet browser to automatically or manually delete cookies. You can also specify whether specific cookies should not be placed. Another option is to set up your internet browser so that you are notified each time a cookie is placed. For more information about these options, see the instructions in the help section of your browser.

Please note that our website may not function properly if all cookies are deactivated. If you delete the cookies in your browser, they will be placed again when you visit our website again.

Special notes on Google Analytics
We have activated IP anonymization for the use of Google Analytics. This means that your IP address will be shortened by Google within member states of the European Union or in other contracting states of the Agreement on the European Economic Area before being transmitted to the USA.

You can prevent the collection of your data by Google Analytics by downloading and installing the browser plugin available at the following link: https://tools.google.com/dlpage/gaoptout?hl=de

Your rights in relation to personal data
You have the following rights in relation to your personal data:

You have the right to know why your personal data is used, what happens to it and how long it is stored.
Right of access: You have the right to view your personal data known to us.
Right to rectification: You have the right to have your personal data completed, corrected, deleted or blocked at any time.
If you have given us your consent to process your data, you have the right to withdraw this consent and have your personal data deleted.
Right to data portability: You have the right to request all your personal data from one controller and to transfer it in its entirety to another controller.
Right to object: You can object to the processing of your data. We will comply unless there are legitimate grounds for the processing.
To exercise these rights, please contact us at:

iQMedix GmbH
Cubex One
Franz-Volhard-Str. 5
68167 Mannheim
Germany
Phone: +49 (0)621 5957 0991
E-mail: datenschutz@iQMedix.eu

If you have a complaint about how we handle your data, we would like to hear it, but you also have the right to address it to the supervisory authority (Data Protection Authority):

The State Commissioner for Data Protection and Freedom of Information Baden-Württemberg
P.O. Box 10 29 32
70025 Stuttgart
Tel.: 0711/61 55 41 – 0
E-mail: poststelle@lfdi.bwl.de

website made by NICKLAS+NICKLAS

Kontaktieren Sie uns zu jeder Zeit

WIR BERATEN SIE KOSTENLOS!

Wir nehmen uns die zeit für Sie

Fallbeispiel Lucas P.

Wie geht es Lucas mit dem
iQMedix-Test?

“Kaum zu glauben, dass ein einfacher Bluttest meinen Krebs unter Kontrolle brachte! Er wies mir den Weg über komplementäre Substanzen schnell und nebenwirkungsarm in 4 Wochen den Krebs um 50% zum Schrumpfen zu bringen. Die nachfolgende Chemo, die der Test als effektiv anzeigte, gab dem Tumor den Rest! Heute bin ich seit 2 Jahren wieder top fit!” sagt Lucas.

Lucas kannte den iQMedix-Test ursprünglich nicht. Sein Arzt bestellte das kostenlose Blutentnahmekit und 2 Tage später gab Lucas sein Blut ab, das sofort ins Labor gesendet und mit modernster Genexpressionsdiagnostik untersucht wurde. Der ausführliche Bericht zeigte seinem behandelnden Arzt die komplementären und zugelasse- nen pharmazeutischen Substanzen mit maximaler Effek- tivität bei minimalen Nebenwirkungen an.

Damit erhalten der Arzt und Patient eine ganzheitliche Übersicht über die personalisierten und nebenwirkungs- armen Therapieoptionen, die nicht im vorgefasstem Schubladendenkenstecken bleibt.

Wir nehmen uns die zeit für Sie

iPREVENT

Der Bluttest zur frühen Erkennung oder zum Monitoring von Krebs

Schon sehr früh geben Tumore Krebszellen in das Blut ab (zirkulierende Tumorzellen – CTC). Wenn diese sich an anderer Stelle im Körper ansiedeln, entstehen daraus Metastasen. iPrevent erfasst im Blut zirkulierende Tumorzellen oft schon in einem sehr frühen Stadium, wenn bildgebende Verfahren (Ultraschall, CT, MRT) noch nichts anzeigen.

Wird eine größere Zahl solcher Zellen gefunden, dann kann der iSelect oder iComplete Test angeschlossen werden.
Damit kann eine Tumorerkrankung meist in frühen Stadien erkannt und adäquat behandelt werden. Eine frühe Behandlung erhöht meist den Erfolg und die Überlebenschancen deutlich. Die sanfteren Therapieoptionen in frühen Phasen lassen auch deutlich geringere Nebenwirkungen erwarten.

DER iPREVENT TEST LIEFERT ENTSCHEIDENDE VORTEILE:

Kontaktieren Sie uns zu jeder Zeit

WIR BERATEN SIE KOSTENLOS!

Wir nehmen uns die zeit für Sie

iSELECT

Die umfassende personalisierte Tumordiagnostik für komplementäre Therapeutika

Der iSelect Test führt ein komplettes Panel von 85+ Genexpressionen durch. Der Test fokussiert sich auf die Gene, die für das Wachstum des Tumors von besonderer Bedeutung sind und den Krebs charakterisieren.
Der Vorteil des iSelect Tests besteht darin, dass unabhängig vom Krebstyp ein Bild von über 85 Merkmalen eines Tumors erfasst wird und somit für den Patienten ein personalisiertes Aktivitätsprofil des Tumors erzeugt wird. Über anerkannte erstklassige Studien werden dann daraus zielgerichtete Therapieoptionen mit komplementären Substanzen (Pflanzenstoffe und Off-Label Medikamente) aufgezeigt. Abgestimmt auf die frühen Stadien der Erkrankung erhält man individuelle Therapieansätze, die gleichzeitig möglichst effektiv und dabei möglichst nebenwirkungsarm sind.

Der iSelect Test gewinnt Genexpressionsprofile aus dem Blut des Patienten.
Eine Genexpression zeigt an, in welchem Maße ein Gen aktiv ist und damit auch die davon abhängigen Signal- und Stoffwechselwege in der Tumorzelle. So kann z.B. eine überhöhte BCL2-Expression Hinweise geben, dass der natürliche Zelltod im Tumor verhindert wird und eine Behandlung z.B. Pflanzenstoffen und Off-Label Medikamenten eine mögliche Therapieoption darstellt.

Der iSelect Test ordnet auf Basis von wissenschaftlichen Studien dem individuellen Aktivitätsprofil des Tumors komplementäre Medikamente zu (natürliche Substanzen oder Off-Label-Medikamente), die die fehlgesteuerte Aktivität wieder ausgleichen können. Die Ergebnisse des Tests werden in einem leichtverständlichen ausführlichen Bericht dargestellt.

Im Verlauf der Erkrankung wird der Test eingesetzt, um während und nach einer Tumortherapie Auskunft über Veränderungen in Signal- und Stoffwechselpfaden zu erhalten, die auf ein Rezidiv hindeuten können. Die Therapie kann dann entsprechend angepasst werden.

DER iSELECT TEST LIEFERT ENTSCHEIDENDE ERKENNTNISSE BEZÜGLICH

Und Sie erhalten einen ausführlichen Bericht über alle komplementären Therapieoptionen, die entsprechend der Genexpressionsanalyse Ihrem medizinischen Team für Ihre Behandlung zur Verfügung stehen.

Kontaktieren Sie uns zu jeder Zeit

WIR BERATEN SIE KOSTENLOS!

Wir nehmen uns die zeit für Sie

iCOMPLETE

Der Bluttest zur umfassenden Analyse der Aktivität und möglichst breiter Behandlungsoptionen Ihres Tumors

Der iComplete Test führt ein komplettes Panel von 85+ Genexpressionen durch. Der Test fokussiert sich auf die Gene, die für das Wachstum des Tumors von besonderer Bedeutung sind und den Krebs charakterisieren.

Der Vorteil des iComplete Tests besteht darin, dass unabhängig vom Krebstyp ein komplettes Bild der besonders relevanten Aktivitäten eines Tumors erfasst wird und somit für den Patienten personalisierte und zielgerichtete Therapieoptionen aufgezeigt werden. Entsprechend dem Stadium der Erkrankung erhält man individuelle Therapieoptionen, die gleichzeitig möglichst effektiv und dabei möglichst nebenwirkungsarm sind.

Der iComplete Test gewinnt Genexpressionsprofile aus dem Blut des Patienten.
Eine Genexpression zeigt an, in welchem Maße ein Gen aktiv ist und damit auch die davon abhängigen Signal- und Stoffwechselwege in der Tumorzelle.

Der iComplete Test analysiert auf Basis von wissenschaftlichen Studien, welche zugelassenen Medikamente, einschließlich Chemotherapeutika, zielgerichtete Medikamente und Immuntherapien sowie natürliche Substanzen oder Off-Label-Medikamente die Signalpfade oder Stoffwechselpfade beeinflussen können. Die Ergebnisse des Tests werden in einem leicht verständlichen ausführlichen Bericht dargestellt.

Im Verlauf der Erkrankung wird der Test eingesetzt, um während und nach einer Tumortherapie Auskunft über Veränderungen in Signal- und Stoffwechselpfaden zu erhalten, die auf ein Rezidiv hindeuten können. Die Therapie kann dann entsprechend angepasst werden.

DER iCOMPLETE TEST LIEFERT ENTSCHEIDENDE ERKENNTNISSE BEZÜGLICH

Und Sie erhalten einen ausführlichen Bericht über alle schulmedizinischen und komplementären Therapieoptionen, die die Genexpressionsanalyse als besonders erfolgsversprechend beurteilt und die Ihr medizinisches Team dann umsetzen kann.

Kontaktieren Sie uns zu jeder Zeit

WIR BERATEN SIE KOSTENLOS!

Wir nehmen uns die zeit für Sie

Wir wünschen Ihnen eine gute Anfahrt

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

We take the time for you

Case study Lucas P.

How is Lucas doing with the
iQMedix test?

“It's hard to believe that a simple blood test brought my cancer under control! It showed me the way to shrink the cancer by 50% in 4 weeks using complementary substances quickly and with few side effects. The subsequent chemo, which the test showed to be effective, put an end to the tumor! Today I've been fit again for 2 years!” says Lucas.

Lucas was not originally aware of the iQMedix test. His doctor ordered the free blood collection kit and two days later Lucas gave his blood, which was immediately sent to the laboratory and analyzed using state-of-the-art gene expression diagnostics. The detailed report showed his treating doctor the complementary and approved pharmaceutical substances with maximum efficacy and minimal side effects.

This gives the doctor and patient a holistic overview of personalized therapy options with few side effects that does not remain stuck in a preconceived box.

We take the time for you

iPREVENT

The blood test for early detection or monitoring of cancer

Tumors release cancer cells into the blood (circulating tumor cells – CTC) at a very early stage. If these cells settle elsewhere in the body, they develop into metastases. iPREVENT often detects circulating tumor cells in the blood at a very early stage, when imaging methods (ultrasound, CT, MRI) do not yet show anything.

If a large number of such cells are found, the iSelect or iComplete test can be connected.
This means that tumors can usually be detected at an early stage and treated appropriately. Early treatment usually significantly increases success and the chances of survival. The gentler treatment options in the early stages also mean that significantly fewer side effects can be expected.

THE iPREVENT TEST OFFERS DECISIVE ADVANTAGES:

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

We take the time for you

iSELECT

Comprehensive personalized tumor diagnostics for complementary therapeutics

The iSELECT test performs a complete panel of 85+ gene expressions. The test focuses on the genes that are of particular importance for the growth of the tumour and characterize the cancer.
The advantage of the iSELECT test is that it captures a picture of over 85 features of a tumour, regardless of the type of cancer, and thus generates a personalized activity profile of the tumour for the patient. Recognized first-class studies are then used to identify targeted therapy options with complementary substances (plant substances and off-label drugs). Tailored to the early stages of the disease, individual therapy approaches are obtained that are both as effective as possible and have as few side effects as possible.

The iSELECT test obtains gene expression profiles from the patient’s blood.
Gene expression indicates the extent to which a gene is active and thus also the signaling and metabolic pathways in the tumor cell that depend on it. For example, excessive BCL2 expression can indicate that natural cell death in the tumor is being prevented and that treatment with plant substances and off-label drugs, for example, is a possible therapeutic option.

Based on scientific studies, the iSELECT test assigns complementary drugs (natural substances or off-label drugs) to the individual activity profile of the tumor, which can compensate for the misdirected activity. The results of the test are presented in an easy-to-understand, detailed report.

During the course of the disease, the test is used to obtain information about changes in signal and metabolic pathways during and after tumor therapy that may indicate a recurrence. The therapy can then be adjusted accordingly.

THE iSELECT TEST PROVIDES CRUCIAL INSIGHTS INTO

And you will receive a detailed report on all complementary therapy options available to your medical team for your treatment according to the gene expression analysis.

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

We take the time for you

iCOMPLETE

The blood test for a comprehensive analysis of your tumor's activity and the widest possible range of treatment options

The iComplete test performs a complete panel of 85+ gene expressions. The test focuses on the genes that are of particular importance for the growth of the tumour and characterize the cancer.

The advantage of the iComplete test is that, regardless of the type of cancer, a complete picture of the particularly relevant activities of a tumour is recorded and thus personalized and targeted therapy options are identified for the patient. Depending on the stage of the disease, individual treatment options are provided that are both as effective as possible and have as few side effects as possible.

The iComplete test obtains gene expression profiles from the patient’s blood.
Gene expression indicates the extent to which a gene is active and thus also the signaling and metabolic pathways in the tumor cell that depend on it.

Based on scientific studies, the iComplete test analyzes which approved drugs, including chemotherapeutics, targeted drugs and immunotherapies as well as natural substances or off-label drugs can affect the signaling pathways or metabolic pathways. The results of the test are presented in an easy-to-understand detailed report.

During the course of the disease, the test is used to obtain information about changes in signaling and metabolic pathways during and after tumor therapy that may indicate a recurrence. The therapy can then be adjusted accordingly.

THE iCOMPLETE TEST PROVIDES CRUCIAL INSIGHTS INTO

And you will receive a detailed report on all conventional and complementary therapy options that the gene expression analysis considers particularly promising and that your medical team can then implement.

Contact us at any time

WE ADVISE YOU FREE OF CHARGE!

We take the time for you

We wish you a pleasant journey